In addition, PSVII@MCP-CaP significantly reduced the protein expressions of CD44, MMP-9 and N-cadherin in drug-resistant colon cancer tissue, while the expression of E-cadherin was increased (Fig. 8D, E). Here, CD44 is linked to malignant colon neoplasm.